This Study is multicenter, non-interventional, ambispective registry to evaluate the demographic and clinical characteristics, therapeutic approaches and outcomes in COPD outpatients with frequent exacerbations in Moscow
Age range
18 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
To describe the baseline mean age of outpatients with COPD in Moscow.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline Demographic data characterisics of outpatients with COPD in Moscow.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline Negative lifestyle factors of outpatients with COPD in Moscow.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline Anthropometry data characterisics of outpatients with COPD in Moscow.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline mean smoking index .
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline mean duration of smoking
Timeframe: 52 weeks of retrospective data before visit 1
To describe a COPD clinical course of outpatients with COPD in Moscow
AstraZeneca Clinical Study Information Center
Timeframe: 52 weeks of retrospective data before visit 1
To describe a COPD exacerbation of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe a severe COPD exacerbation of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe a COPD drug therapy of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe a Spirometry parameters at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe a FEV1 / FVC ratio at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe Blood eosinophils count at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe CAT questionnaire score at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe Healthcare resource utilization of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe COPD comorbidities at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe COPD and Heart Failure comorbidity at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe LVEF at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe COPD and Chronic Kidney Disease comorbidity at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe COPD and Arterial Hypertension (AH) comorbidity at baseline of outpatients with COPD in Moscow
Timeframe: 52 weeks of retrospective data before visit 1
To describe blood pressure at baseline of outpatients with COPD in Moscow
Timeframe: at visit 1
To describe a treatment of comorbidities at baseline of outpatients with COPD in Moscow
Timeframe: at visit 1